story of the week
Adverse Event Profile Differences Between Rituximab and Ocrelizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adverse Event Profile Differences Between Rituximab and Ocrelizumab: Findings From the FDA Adverse Event Reporting Database
Mult. Scler. 2021 Jun 01;27(7)1066-1076, NG Caldito, A Shirani, A Salter, O StuveFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.